ALS Drug NRG5051 Targets Mitochondrial Pore to Protect Neurons9 September 2026Longevity Pulse Read more https://www.nrgtherapeutics.com/wp-content/uploads/2026/10/LPulse_090926.jpg 533 800 Webadm https://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.png Webadm2026-09-09 10:05:482026-10-19 14:20:44ALS Drug NRG5051 Targets Mitochondrial Pore to Protect Neurons